Endpoints News ٦ أبريل ٢٠٢٦ Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
Endpoints News ٤ فبراير ٢٠٢٦ FDA seeks withdrawal of Amgen's Tavneos, company says it won't pull drug
Endpoints News ١٢ ديسمبر ٢٠٢٥ FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Endpoints News ١١ ديسمبر ٢٠٢٥ Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO